Announcements Trials
Browse Landscape

Phase

Phase 2 50Phase 3 28Phase NA 16Phase 1/2 7Phase 4 4Phase 2/3 3Phase 1 3

Status

Unknown 2Completed 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 5Gastrointestinal 5Thoracic 4Breast 4Lymphoid 3Plasma cell 1Other solid neoplasm 1Head & Neck 1Genitourinary 1

Conditions

Breast Neoplasms 3Patient Acceptance of Health Care 1HER-2 Negative Breast Cancer 1

Interventions

Letrozole 23Docetaxel 17Cyclophosphamide 13Zoledronic Acid 12Trastuzumab 12Anastrozole 12exemestane 11Tamoxifen 11Paclitaxel 11Capecitabine 10Fulvestrant 8Epirubicin 8pegfilgrastim 7Saline Solution 7Bupivacaine 7pertuzumab 6liposomal doxorubicin 6abemaciclib 6Sodium Chloride 6Filgrastim 6Carboplatin 6pegylated granulocyte colony-stimulating factor 5palbociclib 5Ropivacaine 5Dexmedetomidine 5Bevacizumab 5ribociclib 4eribulin 4Vinorelbine 4Tranexamic Acid 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Drug Therapy × Breast × Clear all
NCT03355157 2024-10-01

PADMA

GBG Forschungs GmbH

Phase 4 Completed
130 enrolled
Breast

Breast Neoplasms, Patient Acceptance of Health Care

NCT05840068 2023-05-03

IGF Level in Breast Cancer Patients Treated With Metformin

Beni-Suef University

Phase 4 Completed
107 enrolled
Breast

Breast Neoplasms

NCT05036005 2023-04-18

NeoON

Institut fuer Frauengesundheit

Phase 4 Unknown
108 enrolled
Breast

Breast Neoplasms

NCT03799692 2019-01-10

Albumin-Bound Paclitaxel Combined With Carboplatin as Neoadjuvant Chemotherapy in Luminal B/HER-2 Negative Breast Cancer

Fudan University

Phase 4 Unknown
78 enrolled
Breast

HER-2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡